established patient-derived ex vivo tumor cultures in order to investigate the possibility of using TNFα and IL-2 encoding oncolytic adenovirus to restore and enhance the tumor reactivity of TILs in the context of immunosuppressive human ovarian cancer (87). Here, TNF is linked to neoplasm.